Owkin, an AI-Biotech Unicorn, Expands to Germany, Austria, and Switzerland to Accelerate Research with Cutting-Edge AI
Owkin, the first end-to-end AI-biotech unicorn specializing in AI-driven precision drug discovery, development, and diagnostics, has announced its expansion into the DACH region (Germany, Austria, and Switzerland). This follows partnerships…
Brenus Pharma Receives the BIG Start-up of the Year Award from French Tech Saint-Etienne Lyon
During its annual event “BIG UP,” French Tech Saint-Etienne Lyon awarded the BIG Start-up of the Year trophy to a start-up that exemplifies the region’s innovation and richness. French Tech…
2024 Antibiotic Collaboration Trends: 133 Deals by Top Life Science Companies Since 2016
The Antibiotic Collaboration and Licensing Deals 2016-2024 report has been added to ResearchAndMarkets.com’s offerings. This report provides a comprehensive understanding and unprecedented access to antibiotic deals made by the world’s…
Genentech Updates Phase II/III SKYSCRAPER-06 Study in Advanced Non-Squamous Non-Small Cell Lung Cancer
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that its Phase II/III SKYSCRAPER-06 study did not achieve its primary endpoints in evaluating tiragolumab in…
LeadershipLeadership Transition at BenevolentAI
BenevolentAI (Euronext Amsterdam: BAI), a pioneering force in applying advanced artificial intelligence (AI) to expedite biopharma drug discovery, has announced changes to its Executive Leadership Team (ELT) following the recent…
Owkin, Leading AI-Biotech Innovator, Expands Cutting-Edge AI to Germany, Austria, and Switzerland to Advance Research
Owkin, the pioneering AI-biotech unicorn specializing in AI-driven precision drug discovery, development, and diagnostics, has launched its expansion into the DACH region (Germany, Austria, and Switzerland). This expansion follows strategic…
Brenus Pharma Takes Home French Tech Saint-Etienne Lyon’s Prestigious Start-up of the Year Prize
During its annual event “BIG UP,” French Tech Saint-Etienne Lyon awarded the prestigious BIG Start-up of the Year trophy, recognizing a start-up that embodies innovation and vitality within the region.…
32 Athletes from Bayer Sports Clubs Head to the Summer Games in Paris
Exactly 120 years after the establishment of “Turn- und Spielverein der Farbenfabriken vorm. Friedr. Bayer & Co.”, the first Bayer sports club in Germany, Bill Anderson, CEO of Bayer AG,…
EU CHMP Recommends Lynparza and Imfinzi Combo for Advanced/Recurrent Endometrial Cancer
AstraZeneca’s Imfinzi (durvalumab) and Lynparza (olaparib) have been recommended for approval in the European Union (EU) for patients with primary advanced or recurrent endometrial cancer. The combination of Imfinzi plus…
Sipavibart EMA Regulatory Submission Approved for Accelerated Assessment in COVID-19 Prevention
AstraZeneca’s Marketing Authorisation Application (MAA) for sipavibart has been accepted under the accelerated assessment procedure by the European Medicines Agency (EMA) for the pre-exposure prophylaxis (prevention) of COVID-19 in immunocompromised…
Robert A. Michael Appointed as CEO of AbbVie
AbbVie announced today that Robert A. Michael has taken on the role of Chief Executive Officer (CEO) and joined the company’s Board of Directors, effective immediately. As previously announced, Mr.…
Merck Secures Global Rights to Opevesostat for Prostate Cancer
MSD (known as Merck & Co., Inc. in the US and Canada) and Orion Corporation announced the mutual exercise of an option to convert their co-development and co-commercialization agreement for…